Vertex Pharmaceuticals Inc / Ma

Norinchukin Bank, The VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

24,203

Value ($000)

10,973

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	10,973	0.1%	24,203	12/31/2025
2025 Q3	11/14/2025	8,626	0.1%	22,026	9/30/2025
2025 Q2	8/14/2025	9,766	0.1%	21,936	6/30/2025
2025 Q1	5/14/2025	9,734	0.2%	20,077	3/31/2025
2024 Q4	2/13/2025	5,620	0.1%	13,957	12/31/2024
2024 Q3	11/14/2024	5,977	0.1%	12,851	9/30/2024
2024 Q2	8/14/2024	5,219	0.1%	11,135	6/30/2024
2024 Q1	5/14/2024	4,652	0.1%	11,130	3/31/2024
2023 Q4	2/13/2024	4,625	0.1%	11,367	12/31/2023
2023 Q3	11/13/2023	4,530	0.1%	13,026	9/30/2023
2023 Q2	8/14/2023	9,441	0.2%	26,829	6/30/2023
2023 Q1	5/12/2023	6,367	0.1%	20,207	3/31/2023
2022 Q4	2/13/2023	5,685	0.1%	19,685	12/31/2022
2022 Q3	11/14/2022	6,971	0.1%	24,076	9/30/2022
2022 Q2	8/10/2022	6,097	0.1%	21,638	6/30/2022
2022 Q1	5/12/2022	6,878	0.1%	26,357	3/31/2022
2021 Q4	2/10/2022	5,243	0.1%	23,875	12/31/2021
2021 Q3	11/9/2021	4,679	0.1%	25,794	9/30/2021
2021 Q2	8/11/2021	4,919	0.1%	24,395	6/30/2021
2021 Q1	5/12/2021	5,196	0.1%	24,178	3/31/2021
2020 Q4	2/12/2021	5,446	0.1%	23,043	12/31/2020
2020 Q3	11/12/2020	6,306	0.1%	23,175	9/30/2020
2020 Q2	8/12/2020	6,502	0.1%	22,397	6/30/2020
2020 Q1	5/13/2020	5,327	0.1%	22,388	3/31/2020
2019 Q4	2/12/2020	7,621	0.1%	34,809	12/31/2019
2014 Q2	7/31/2014	834	0.0%	8,813	6/30/2014
2014 Q1	5/13/2014	690	0.0%	9,756	3/31/2014
2013 Q4	2/14/2014	649	0.0%	8,732	12/31/2013